Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

ClinicalTrials.gov ID: NCT01081145

Public ClinicalTrials.gov record NCT01081145. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 6:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-blind, Placebo-controlled, Multicentre, Randomised Withdrawal, Long-term Maintenance of Efficacy and Safety Study of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 With Attention Deficit/Hyperactivity Disorder

Study identification

NCT ID
NCT01081145
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shire
Industry
Enrollment
528 participants

Conditions and interventions

Interventions

  • Extended-release Guanfacine Hydrochloride Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 10, 2010
Primary completion
Jun 2, 2013
Completion
Jun 2, 2013
Last update posted
Jun 13, 2021

2010 – 2013

United States locations

U.S. sites
27
U.S. states
19
U.S. cities
27
Facility City State ZIP Site status
Harmonex Neuroscience Research Dothan Alabama 36303
Clinical Study Centers, LLC Little Rock Arkansas 72205
Psychiatric Centers at San Diego, Feighner Research San Diego California 92108
Encompass Clinical Research - North Coast Spring Valley California 91978
Elite Clinical Trials, Inc. Wildomar California 92595
Florida Clinical Research Center, LLC Bradenton Florida 34208
Sarkis Clinical Trials Gainesville Florida 32607
Amedica Research Institute, Inc. Hialeah Florida 33013
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32216
Florida Clinical Research Center, LLC Maitland Florida 32751
Clinical Neuroscience Solutions, Inc. Orlando Florida 32806
AMR-Baber Research Inc. Naperville Illinois 60563
Goldpoint Clinical Research, LLC Indianapolis Indiana 46260
Louisiana Research Associates, Inc. New Orleans Louisiana 70114
Delmarva Family Resources Salisbury Maryland 21801
University of Nebraska Medical Center Omaha Nebraska 68198
Center for Psychiatry and Behavioral Medicine, Inc. Las Vegas Nevada 89128
Mount Sinai School of Medicine New York New York 10029
Triangle Neuropsychiatry, PLLC Durham North Carolina 27707
Ohio State University, Nisonger Center Columbus Ohio 43210
IPS Research Company Oklahoma City Oklahoma 73103
Oregon Center for Clinical Investigations, Inc. (OCCI, Inc.) Salem Oregon 97301
CRI Worldwide, LLC Philadelphia Pennsylvania 19139
FutureSearch Clinical Trials Austin Texas 78756
ADHD Clinic of San Antonio San Antonio Texas 78247
Alliance Research Group, LLC Richmond Virginia 23230
Eastside Therapeutic Resource Kirkland Washington 98033

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01081145, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 13, 2021 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01081145 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →